GAMMA Investing’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93M Buy
31,969
+3,567
+13% +$312K 0.11% 149
2026
Q1
$2.42M Buy
28,402
+5,073
+22% +$452K 0.11% 156
2025
Q4
$1.84M Buy
23,329
+12,437
+114% +$975K 0.09% 178
2025
Q3
$871K Sell
10,892
-3,545
-25% -$302K 0.05% 333
2025
Q2
$1.31M Buy
14,437
+2,640
+22% +$241K 0.08% 211
2025
Q1
$1.11M Buy
11,797
+1,468
+14% +$131K 0.08% 229
2024
Q4
$939K Sell
10,329
-623
-6% -$59.5K 0.08% 221
2024
Q3
$1.14M Buy
10,952
+2,677
+32% +$273K 0.11% 171
2024
Q2
$803K Buy
8,275
+3,097
+60% +$286K 0.11% 164
2024
Q1
$466K Buy
5,178
+858
+20% +$72.7K 0.1% 199
2023
Q4
$364K Buy
+4,320
New +$325K 0.1% 176

Other funds holding CL

GAMMA Investing's CL Position: Q2 2026 in Review

GAMMA Investing increased its Colgate-Palmolive (CL) stake by 13% in Q2 2026, buying an estimated $312K and bringing the position to 31,969 shares worth $2.93M. The position accounts for 0.11% of the portfolio, ranked #149.

GAMMA Investing first reported a position in CL in Q4 2023 and has held it in 11 quarters since. 722 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • GAMMA Investing held 31,969 shares of Colgate-Palmolive worth $2.93M as of Q2 2026.
  • GAMMA Investing bought 3,567 Colgate-Palmolive shares in Q2 2026, an estimated $312K.
  • Colgate-Palmolive made up 0.11% of GAMMA Investing's portfolio in Q2 2026, its #149 holding.
  • GAMMA Investing first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • 722 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.